BIOMAT Database Logo BIOMAT Database Logo

ADAR1 RNA editing enzyme regulates R-loop formation and genome stability at telomeres in cancer cells. 2021

Yusuke Shiromoto, and Masayuki Sakurai, and Moeko Minakuchi, and Kentaro Ariyoshi, and Kazuko Nishikura
The Wistar Institute, Philadelphia, PA, USA.

ADAR1 is involved in adenosine-to-inosine RNA editing. The cytoplasmic ADAR1p150 edits 3'UTR double-stranded RNAs and thereby suppresses induction of interferons. Loss of this ADAR1p150 function underlies the embryonic lethality of Adar1 null mice, pathogenesis of the severe autoimmune disease Aicardi-Goutières syndrome, and the resistance developed in cancers to immune checkpoint blockade. In contrast, the biological functions of the nuclear-localized ADAR1p110 remain largely unknown. Here, we report that ADAR1p110 regulates R-loop formation and genome stability at telomeres in cancer cells carrying non-canonical variants of telomeric repeats. ADAR1p110 edits the A-C mismatches within RNA:DNA hybrids formed between canonical and non-canonical variant repeats. Editing of A-C mismatches to I:C matched pairs facilitates resolution of telomeric R-loops by RNase H2. This ADAR1p110-dependent control of telomeric R-loops is required for continued proliferation of telomerase-reactivated cancer cells, revealing the pro-oncogenic nature of ADAR1p110 and identifying ADAR1 as a promising therapeutic target of telomerase positive cancers.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000080870 R-Loop Structures An RNA-DNA hybrid structure formed when newly transcribed RNA remains bound to its DNA template. Stability of R-loops may play a role in GENETIC INSTABILITY. R-Loop,R-Loops,R Loop,R Loop Structures,R Loops,R-Loop Structure
D000243 Adenosine Deaminase An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA. Adenosine Aminohydrolase,Aminohydrolase, Adenosine,Deaminase, Adenosine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016601 RNA-Binding Proteins Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA. Double-Stranded RNA-Binding Protein,Double-Stranded RNA-Binding Proteins,ds RNA-Binding Protein,RNA-Binding Protein,ds RNA-Binding Proteins,Double Stranded RNA Binding Protein,Double Stranded RNA Binding Proteins,Protein, Double-Stranded RNA-Binding,Protein, ds RNA-Binding,RNA Binding Protein,RNA Binding Proteins,RNA-Binding Protein, Double-Stranded,RNA-Binding Protein, ds,RNA-Binding Proteins, Double-Stranded,ds RNA Binding Protein
D016615 Telomere A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs. Telomeres

Related Publications

Yusuke Shiromoto, and Masayuki Sakurai, and Moeko Minakuchi, and Kentaro Ariyoshi, and Kazuko Nishikura
RNA Editing Enzyme ADAR1 Suppresses the Mobility of Cancer Cells via ARPIN.
June 2023, Molecules and cells,
Yusuke Shiromoto, and Masayuki Sakurai, and Moeko Minakuchi, and Kentaro Ariyoshi, and Kazuko Nishikura
SOSS-INTAC Regulates R-loop Accumulation and Genome Stability.
October 2023, Cancer discovery,
Yusuke Shiromoto, and Masayuki Sakurai, and Moeko Minakuchi, and Kentaro Ariyoshi, and Kazuko Nishikura
Long noncoding RNA Lnc530 localizes on R-loops and regulates R-loop formation and genomic stability in mouse embryonic stem cells.
April 2023, Stem cell reports,
Yusuke Shiromoto, and Masayuki Sakurai, and Moeko Minakuchi, and Kentaro Ariyoshi, and Kazuko Nishikura
Corrigendum to: RNA Editing Enzyme ADAR1 Suppresses the Mobility of Cancer Cells via ARPIN.
November 2023, Molecules and cells,
Yusuke Shiromoto, and Masayuki Sakurai, and Moeko Minakuchi, and Kentaro Ariyoshi, and Kazuko Nishikura
RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis.
August 2022, International journal of molecular sciences,
Yusuke Shiromoto, and Masayuki Sakurai, and Moeko Minakuchi, and Kentaro Ariyoshi, and Kazuko Nishikura
A new function for the RNA-editing enzyme ADAR1.
January 2009, Nature immunology,
Yusuke Shiromoto, and Masayuki Sakurai, and Moeko Minakuchi, and Kentaro Ariyoshi, and Kazuko Nishikura
The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
November 2014, Cell reports,
Yusuke Shiromoto, and Masayuki Sakurai, and Moeko Minakuchi, and Kentaro Ariyoshi, and Kazuko Nishikura
The role of RNA editing enzyme ADAR1 in human disease.
January 2022, Wiley interdisciplinary reviews. RNA,
Yusuke Shiromoto, and Masayuki Sakurai, and Moeko Minakuchi, and Kentaro Ariyoshi, and Kazuko Nishikura
Multifaceted roles of RNA editing enzyme ADAR1 in innate immunity.
April 2024, RNA (New York, N.Y.),
Yusuke Shiromoto, and Masayuki Sakurai, and Moeko Minakuchi, and Kentaro Ariyoshi, and Kazuko Nishikura
ADAR1-Mediated RNA Editing and Its Role in Cancer.
January 2022, Frontiers in cell and developmental biology,
Copied contents to your clipboard!